Is forgetfulness a side effect of lamotrigine or quetiapine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Forgetfulness with Lamotrigine or Quetiapine

Both lamotrigine and quetiapine can cause forgetfulness and cognitive impairment, but quetiapine is significantly more likely to cause these effects, particularly through its prominent sedation and anticholinergic properties.

Quetiapine and Cognitive Impairment

Quetiapine has well-documented cognitive side effects that directly contribute to forgetfulness:

Primary mechanisms causing forgetfulness:

  • Somnolence/sedation occurs in 18-57% of patients depending on indication, with the FDA label explicitly warning that quetiapine "has the potential to impair judgment, thinking, or motor skills" 1
  • Anticholinergic effects from its active metabolite norquetiapine, which has "moderate to strong affinity for several muscarinic receptor subtypes" 1. Anticholinergic medications are well-known to impair memory formation and recall
  • The combination of sedation and anticholinergic activity creates a "double hit" on cognitive function

Clinical evidence:

  • In schizophrenia trials, somnolence occurred in 18% of quetiapine patients vs 11% placebo 1
  • In bipolar depression, somnolence reached 57% vs 15% placebo 1
  • Guidelines specifically note quetiapine causes "neurological side effects" and recommend avoiding it for insomnia in primary care due to insufficient efficacy evidence and significant side effects 2

Important caveat: One animal study suggested quetiapine might improve memory in Alzheimer's models 3, but this contradicts human clinical experience and FDA labeling, and should not influence prescribing decisions for typical psychiatric patients.

Lamotrigine and Cognitive Effects

Lamotrigine generally has a favorable cognitive profile compared to other mood stabilizers and antipsychotics:

Evidence supporting cognitive safety:

  • Treatment with lamotrigine as monotherapy was associated with improved cognitive functioning in bipolar patients, with significant improvements in Medical Outcomes Study Cognitive Scale scores (+32.2 points in depressed patients, +19.9 in manic patients) 4
  • Lamotrigine is "generally accepted as a well-tolerated medication with few cognitive side effects" 5
  • Studies show lamotrigine has fewer cognitive difficulties than traditional neuroleptics 6

Rare but documented cognitive side effects:

  • Isolated case reports describe severe cognitive dysfunction, including "dementia-like process" and "Wernicke-like dysphasia" that reversed with dose reduction 5
  • One pediatric case reported "cognitive decline" with eye movement abnormalities that resolved after discontinuation 7
  • These appear to be idiosyncratic reactions rather than dose-dependent effects in most patients

Clinical Recommendations

If a patient reports forgetfulness:

  1. On quetiapine alone: Quetiapine is the likely culprit. Consider:

    • Dose reduction if clinically feasible
    • Switching to an alternative with less sedation/anticholinergic activity
    • Timing the dose at bedtime to minimize daytime cognitive impact
    • Therapeutic drug monitoring if on high doses or combined with lamotrigine (see interaction below)
  2. On lamotrigine alone: Lamotrigine is unlikely to be the cause. Investigate:

    • Underlying mood disorder (depression strongly correlates with cognitive complaints 4)
    • Other medications with anticholinergic or sedating properties
    • Medical causes of cognitive impairment
    • If lamotrigine is strongly suspected, consider dose reduction or discontinuation trial
  3. On both medications: Quetiapine remains the primary suspect, but be aware:

    • Lamotrigine doses >200 mg/day reduce quetiapine immediate-release concentrations by 46%, potentially leading to inadequate treatment and breakthrough mood symptoms that impair cognition 8
    • This interaction does NOT occur with quetiapine extended-release formulations 8, 9
    • Consider therapeutic drug monitoring of quetiapine if using IR formulation with high-dose lamotrigine

Common pitfall: Attributing cognitive complaints to the mood disorder itself rather than medication side effects. While depression does impair cognition, quetiapine's sedation and anticholinergic effects are independent contributors that warrant medication adjustment 1, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.